ASX - By Stock
|
AVR |
Re:
Ann: Half Yearly Report and Accounts
|
|
ashtool
|
210 |
68K |
3 |
26/02/17 |
26/02/17 |
ASX - By Stock
|
210
|
68K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Half Yearly Report and Accounts
|
|
ashtool
|
210 |
68K |
1 |
26/02/17 |
26/02/17 |
ASX - By Stock
|
210
|
68K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus Announces Half Yearly Report
|
|
ashtool
|
11 |
3.9K |
2 |
25/02/17 |
25/02/17 |
ASX - By Stock
|
11
|
3.9K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Half Yearly Report and Accounts
|
|
ashtool
|
210 |
68K |
1 |
24/02/17 |
24/02/17 |
ASX - By Stock
|
210
|
68K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Half Yearly Report and Accounts
|
|
ashtool
|
210 |
68K |
0 |
24/02/17 |
24/02/17 |
ASX - By Stock
|
210
|
68K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Half Yearly Report and Accounts
|
|
ashtool
|
210 |
68K |
8 |
24/02/17 |
24/02/17 |
ASX - By Stock
|
210
|
68K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Half Yearly Report and Accounts
|
|
ashtool
|
210 |
68K |
2 |
24/02/17 |
24/02/17 |
ASX - By Stock
|
210
|
68K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Half Yearly Report and Accounts
|
|
ashtool
|
210 |
68K |
5 |
24/02/17 |
24/02/17 |
ASX - By Stock
|
210
|
68K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Half Yearly Report and Accounts
|
|
ashtool
|
210 |
68K |
3 |
24/02/17 |
24/02/17 |
ASX - By Stock
|
210
|
68K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Half Yearly Report and Accounts
|
|
ashtool
|
210 |
68K |
2 |
24/02/17 |
24/02/17 |
ASX - By Stock
|
210
|
68K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Initial Director's Interest Notice
|
|
ashtool
|
36 |
10K |
1 |
23/02/17 |
23/02/17 |
ASX - By Stock
|
36
|
10K
|
1
|
|
ASX - By Stock
|
RHC |
Re:
Ann: Dividend/Distribution - RHC
|
|
ashtool
|
63 |
26K |
0 |
23/02/17 |
23/02/17 |
ASX - By Stock
|
63
|
26K
|
0
|
|
ASX - By Stock
|
RHC |
Re:
Ann: Ramsay MD/CEO Succession
|
|
ashtool
|
1 |
703 |
0 |
23/02/17 |
23/02/17 |
ASX - By Stock
|
1
|
703
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Director Appointment/Resignation
|
|
ashtool
|
17 |
7.2K |
2 |
17/02/17 |
17/02/17 |
ASX - By Stock
|
17
|
7.2K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Admedus appoints new public relations consultant
|
|
ashtool
|
15 |
5.8K |
5 |
16/02/17 |
16/02/17 |
ASX - By Stock
|
15
|
5.8K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Wealth destroyer
|
|
ashtool
|
148 |
48K |
33 |
16/02/17 |
16/02/17 |
ASX - By Stock
|
148
|
48K
|
33
|
|
ASX - By Stock
|
AVR |
Re:
Reasons to be positive
|
|
ashtool
|
29 |
12K |
0 |
16/02/17 |
16/02/17 |
ASX - By Stock
|
29
|
12K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Reasons to be positive
|
|
ashtool
|
29 |
12K |
0 |
16/02/17 |
16/02/17 |
ASX - By Stock
|
29
|
12K
|
0
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Half Year Results Analysts Presentation
|
|
ashtool
|
41 |
14K |
0 |
15/02/17 |
15/02/17 |
ASX - By Stock
|
41
|
14K
|
0
|
|
ASX - By Stock
|
CSL |
Re:
News: CSL CSL says FDA accepts CSL Behring's biologics license application supplement for using...
|
|
ashtool
|
1 |
845 |
0 |
15/02/17 |
15/02/17 |
ASX - By Stock
|
1
|
845
|
0
|
|
ASX - By Stock
|
COH |
Re:
News: UPDATE 1-Australia's Cochlear posts 19 pct profit rise
|
|
ashtool
|
8 |
2.6K |
0 |
14/02/17 |
14/02/17 |
ASX - By Stock
|
8
|
2.6K
|
0
|
|
ASX - By Stock
|
COH |
Re:
News: UPDATE 1-Australia's Cochlear posts 19 pct profit rise
|
|
ashtool
|
8 |
2.6K |
0 |
14/02/17 |
14/02/17 |
ASX - By Stock
|
8
|
2.6K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Somebody's left the building
|
|
ashtool
|
22 |
10K |
1 |
13/02/17 |
13/02/17 |
ASX - By Stock
|
22
|
10K
|
1
|
|
ASX - By Stock
|
REA |
Re:
News: REA Rea Group says Hy revenue from ordinary activities $337.3 mln, up 16%
|
|
ashtool
|
8 |
4.6K |
2 |
10/02/17 |
10/02/17 |
ASX - By Stock
|
8
|
4.6K
|
2
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Ceasing to be a substantial holder
|
|
ashtool
|
4 |
2.1K |
1 |
06/02/17 |
06/02/17 |
ASX - By Stock
|
4
|
2.1K
|
1
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Ceasing to be a substantial holder
|
|
ashtool
|
4 |
2.1K |
0 |
06/02/17 |
06/02/17 |
ASX - By Stock
|
4
|
2.1K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
ashtool
|
247 |
75K |
0 |
02/02/17 |
02/02/17 |
ASX - By Stock
|
247
|
75K
|
0
|
|
ASX - By Stock
|
RHC |
Re:
Downward trend confirmed.
|
|
ashtool
|
182 |
75K |
1 |
01/02/17 |
01/02/17 |
ASX - By Stock
|
182
|
75K
|
1
|
|
ASX - By Stock
|
RHC |
Re:
Downward trend confirmed.
|
|
ashtool
|
182 |
75K |
1 |
01/02/17 |
01/02/17 |
ASX - By Stock
|
182
|
75K
|
1
|
|
ASX - By Stock
|
RHC |
Re:
Downward trend confirmed.
|
|
ashtool
|
182 |
75K |
1 |
01/02/17 |
01/02/17 |
ASX - By Stock
|
182
|
75K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
ashtool
|
247 |
75K |
1 |
31/01/17 |
31/01/17 |
ASX - By Stock
|
247
|
75K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
4C predictions anyone?
|
|
ashtool
|
200 |
75K |
3 |
30/01/17 |
30/01/17 |
ASX - By Stock
|
200
|
75K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
4C predictions anyone?
|
|
ashtool
|
200 |
75K |
4 |
24/01/17 |
24/01/17 |
ASX - By Stock
|
200
|
75K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
4C predictions anyone?
|
|
ashtool
|
200 |
75K |
0 |
24/01/17 |
24/01/17 |
ASX - By Stock
|
200
|
75K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
4C predictions anyone?
|
|
ashtool
|
200 |
75K |
0 |
24/01/17 |
24/01/17 |
ASX - By Stock
|
200
|
75K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
4C predictions anyone?
|
|
ashtool
|
200 |
75K |
0 |
24/01/17 |
24/01/17 |
ASX - By Stock
|
200
|
75K
|
0
|
|
ASX - By Stock
|
RHC |
Re:
does this make sense
|
|
ashtool
|
7 |
6.1K |
2 |
09/01/17 |
09/01/17 |
ASX - By Stock
|
7
|
6.1K
|
2
|
|
ASX - By Stock
|
AVR |
Equity Story
|
|
ashtool
|
2 |
1.7K |
9 |
14/12/16 |
14/12/16 |
ASX - By Stock
|
2
|
1.7K
|
9
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Daily share buy-back notice - Appendix 3E
|
|
ashtool
|
12 |
8.4K |
1 |
12/12/16 |
12/12/16 |
ASX - By Stock
|
12
|
8.4K
|
1
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Daily share buy-back notice - Appendix 3E
|
|
ashtool
|
1 |
1.2K |
0 |
06/12/16 |
06/12/16 |
ASX - By Stock
|
1
|
1.2K
|
0
|
|
ASX - By Stock
|
CSL |
Re:
Buying??
|
|
ashtool
|
44 |
22K |
2 |
05/12/16 |
05/12/16 |
ASX - By Stock
|
44
|
22K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Most undervalued stock
|
|
ashtool
|
268 |
91K |
10 |
30/11/16 |
30/11/16 |
ASX - By Stock
|
268
|
91K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Most undervalued stock
|
|
ashtool
|
268 |
91K |
0 |
25/11/16 |
25/11/16 |
ASX - By Stock
|
268
|
91K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Most undervalued stock
|
|
ashtool
|
268 |
91K |
0 |
23/11/16 |
23/11/16 |
ASX - By Stock
|
268
|
91K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Equity Story 22/11/16
|
|
ashtool
|
5 |
1.8K |
0 |
23/11/16 |
23/11/16 |
ASX - By Stock
|
5
|
1.8K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Most undervalued stock
|
|
ashtool
|
268 |
91K |
0 |
22/11/16 |
22/11/16 |
ASX - By Stock
|
268
|
91K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: CardioCel receives market approval in UAE
|
|
ashtool
|
32 |
13K |
17 |
21/11/16 |
21/11/16 |
ASX - By Stock
|
32
|
13K
|
17
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Afstyla CHMP Recommendation
|
|
ashtool
|
4 |
2.0K |
1 |
14/11/16 |
14/11/16 |
ASX - By Stock
|
4
|
2.0K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
AGM (10/11/16)
|
|
ashtool
|
117 |
38K |
11 |
10/11/16 |
10/11/16 |
ASX - By Stock
|
117
|
38K
|
11
|
|
ASX - By Stock
|
AVR |
AGM (10/11/16)
|
|
ashtool
|
117 |
38K |
5 |
10/11/16 |
10/11/16 |
ASX - By Stock
|
117
|
38K
|
5
|
|